ALK-Abello A/S (AKBLF)

36.10 0.00 (0.00%) USD  |  OTCM  |  Jan 16, 16:00
More

ALK-Abello EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AKBLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Genmab A/S Upgrade
Ascendis Pharma A/S Upgrade
Evaxion AS Upgrade
IO Biotech, Inc. Upgrade